Chembio Diagnostics Inc (NASDAQ:CEMI) Announces Results Of Its Latest Clinical Trial
The stock of Chembio Diagnostics Inc (NASDAQ:CEMI) closed at $7.70 gaining 0.65% in yesterday’s trading session. Chembio Diagnostics has already completed its most recent clinical […]